Trial Profile
Management of Insomnia in Breast Cancer Patients: A Preliminary Pilot Study.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Aug 2020
Price :
$35
*
At a glance
- Drugs Armodafinil (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- 13 Sep 2018 Status changed from active, no longer recruiting to completed.
- 24 Nov 2015 Planned End Date changed from 1 Dec 2013 to 1 Jul 2016 as reported by ClinicalTrials.gov record
- 24 Nov 2015 Planned primary completion date changed to 1 Jul 2016 as reported by ClinicalTrials.gov record.